Company intelligence / Profile preview

GeneChem Technologies Venture Fund

Montreal, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

GeneChem is a Montreal-based venture capital firm exclusively dedicated to the life sciences sector. Founded in 1997, the firm manages several specialized funds, including the GeneChem Technologies Venture Fund and the GeneChem Therapeutics Venture Fund, which focus on early-stage investments in biotechnology and pharmaceutical companies. GeneChem provides both capital and strategic expertise to help portfolio companies develop innovative therapies and medical technologies. The firm has played a significant role in the Canadian biotech ecosystem, supporting the growth of numerous startups from inception through clinical development.

Industry: Investors

Beyond the preview

Go deeper on GeneChem Technologies Venture Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneChem Technologies Venture Fund.

Explore the full profile